一种针对两个不同的CD73表位体的抗体尾酒增强了酶抑制和瘤控制
Jin-Gen Xu1,2, Shi Chen2, Yang He3
1Key Laboratory of Immune Response and Immunotherapy, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Scienes, Guangzhou, China.
Nature communications
|December 31, 2024
概括
一种新的抗体尾酒,HB0045,向CD73 (免疫抑制瘤中的酶),以抑制癌症生长. 这种尾酒增强了T细胞的增殖,与单个抗体相比,显示出优异的瘤抑制.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 结构生物学 结构生物学
背景情况:
- 在免疫抑制性瘤微环境中,CD73类生态酶提升了腺.
- CD73抑制是对表达CD73的癌症的一个有前途的治疗策略.
研究的目的:
- 开发和描述一种新的治疗性抗人类CD73抗体尾酒,HB0045.
- 研究HB0045.5的作用机制和体内疗效.
主要方法:
- 开发了两种人性化的单克隆IgG1抗体 (HB0038和HB0039) 的1:1混合物,形成HB0045尾酒.
- 在体外对T细胞增殖的评估.
- 对HB0045与CD73结合的结构分析.
- 在生体内评估HB0045在同源性和异源移植瘤模型中的疗效.
主要成果:
- 与单亲抗体相比,HB0045证明了增强的T细胞增殖促进.
- 结构分析显示,HB0045通过双锁机制将CD73二次体锁定在非活性构造中.
- 在体内,HB0045表现出比单个抗体更强大的瘤生长抑制.
结论:
- CD73抗体尾酒HB0045为表达CD73的癌症提供了一个强大的治疗策略.
- HB0045的机制涉及锁定CD73二元,增强T细胞反应,并抑制瘤生长.
更多相关视频
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.2K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K